Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

